Metabolomics as a new key actor in systems biology for better understanding nutrition-health relationship
Autor: | Pujos-Guillot, Estelle, Petera, Mélanie, Brandolini-Bunlon, Marion, Liu, Yunfei, Giacomoni, Franck, Comte, Blandine |
---|---|
Přispěvatelé: | Unité de Nutrition Humaine (UNH), Institut National de la Recherche Agronomique (INRA)-Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université, Plate-Forme d'Exploration du Métabolisme, Institut National de la Recherche Agronomique (INRA), INRA DID'IT Metaprogramme, European Association of Systems Medicine e.V. Aachen, DEU., Plateforme Exploration du Métabolisme (PFEM), Institut National de la Recherche Agronomique (INRA)-Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-MetaboHUB-Clermont, MetaboHUB-MetaboHUB, Unité de Nutrition Humaine - Clermont Auvergne (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne (UCA), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Institut National de la Recherche Agronomique (INRA) |
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
nutrition
syndrome métabolique analyse intégrative education metabolic x syndrome biomarker [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie désordre métabolique [INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] biomarqueur [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition health care economics and organizations métabolomique |
Zdroj: | 8. Santorini Conference "Systems Medicine, personalised health and therapy" 8. Santorini Conference "Systems Medicine, personalised health and therapy", Oct 2016, Thira-Santorini, Greece. 2016 1. Conference of the European Association of Systems Medicine (EASyM) 1. Conference of the European Association of Systems Medicine (EASyM), Oct 2016, Berlin, Germany. 223 p., 2016, First Conference of the European Association of Systems Medicine-conference programme 8. Santorini Conference "Systems Medicine, personalised health and therapy", Oct 2016, Thira-Santorini, Greece., 2016 1. Conference of the European Association of Systems Medicine (EASyM), Oct 2016, Berlin, Germany. 223 p., 2016 |
Popis: | International audience; Background: Human body responses to nutrition and chronic metabolic disorders represent complex features that require integrated systems biology approach to better understand their relationship. Metabolomics, as a powerful phenotyping tool offers now the possibility of characterizing global alterations associated with nutritional exposure and/or disease conditions, and of identifying early and/or predictive biomarkers of disease development. Objective: The objective of this work was to perform a proof of concept study of the use of untargeted metabolomics as part of an integrated strategy for identifying predictive biomarkers of the evolution toward Metabolic Syndrome (MetS), and bring new knowledge about this pathological state. Design: A nested case-control approach was used within the French GAZEL cohort (n~20,000): at risk male subjects (n = 111, 54–64 years old) with high body mass index (BMI, 25 ≤ BMI < 30), free of MetS at baseline, were selected. Cases who developed MetS at the follow-up (5 years later) were compared with Controls (matched for BMI and age) for several parameters (clinical, biochemical parameters, and food habits). Baseline serum samples were analyzed using mass spectrometry-based untargeted metabolomics. A full bioinformatics workflow was optimized to process the data. In particular, data mining methods were used to select the best candidate for prediction. Metabolomic data were then integrated with the different parameters from the database to determine whether multidimensional models improve prediction and impact subject stratification. Results: Metabolomic data allowed improving prediction capacity compared to the use of clinical data only. The multidimensional model integrating metabolomics with anthropometric, biochemical and nutritional data showed the best prediction performances. The analysis of the misclassified subjects revealed sub-phenotypes and generated hypotheses about the disease associated feature space, that need further characterization in order to propose adequate patient sub-stratification and prevention. Conclusion: Metabolomics has the potential to become a key player in systems diagnosis strategies. Integration of metabolic profiles into multidimensional models can be an essential tool for a patient- centered personalized prevention |
Databáze: | OpenAIRE |
Externí odkaz: |